The People

Experimental Oral GLP-1 Pill Drives Nearly 12% Weight Loss in Trial

via The Hill·12h ago

An experimental oral GLP-1 drug produced nearly 12% weight loss over 36 weeks in a new study, offering a potential pill-based alternative to injectable treatments. Researchers found the medication stimulates insulin secretion, suppresses appetite and boosts feelings of fullness.

Read Full Story at The Hill
healthscience

Related Stories

Doctors Suspected Brain Cancer. It Was Actually Worms.

Ars Technica·12h ago

A Christian Convert From Yemen Chooses to Live Openly in His Faith

Intl Christian Concern·6h ago

German Theologian Works to Bring Protestants and Catholics Together

Christianity Today·6h ago

'Almost Homeless' Subreddit Offers a Stark Glimpse at Soaring Wealth Inequality

Wired·6h ago
DiscussSoon
← Front Page